146.50
4.32%
-6.61
Zoetis Inc stock is currently priced at $146.50, with a 24-hour trading volume of 6.15M.
It has seen a -4.32% decreased in the last 24 hours and a -15.30% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $152.6 pivot point. If it approaches the $149.1 support level, significant changes may occur.
Zoetis Inc Stock (ZTS) Financials Data
Zoetis Inc (ZTS) Revenue 2024
ZTS reported a revenue (TTM) of $8.54 billion for the quarter ending December 31, 2023, a +5.74% rise year-over-year.
Zoetis Inc (ZTS) Net Income 2024
ZTS net income (TTM) was $2.34 billion for the quarter ending December 31, 2023, a +10.88% increase year-over-year.
Zoetis Inc (ZTS) Cash Flow 2024
ZTS recorded a free cash flow (TTM) of $1.62 billion for the quarter ending December 31, 2023, a +22.25% increase year-over-year.
Zoetis Inc (ZTS) Earnings per Share 2024
ZTS earnings per share (TTM) was $5.07 for the quarter ending December 31, 2023, a +12.67% growth year-over-year.
Zoetis Inc Stock (ZTS) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Lagano Roxanne | Executive Vice President |
Apr 18 '24 |
Sale |
151.17 |
923 |
139,530 |
14,800 |
Lagano Roxanne | Executive Vice President |
Mar 18 '24 |
Sale |
173.33 |
923 |
159,984 |
15,723 |
Reed Willie M | Director |
Mar 11 '24 |
Sale |
182.68 |
1,370 |
250,265 |
9,994 |
PECK KRISTIN C | Chief Executive Officer |
Feb 20 '24 |
Option Exercise |
46.09 |
13,000 |
599,170 |
92,366 |
PECK KRISTIN C | Chief Executive Officer |
Feb 20 '24 |
Sale |
187.20 |
13,000 |
2,433,636 |
79,366 |
Lagano Roxanne | Executive Vice President |
Feb 20 '24 |
Sale |
187.30 |
923 |
172,878 |
16,646 |
Lagano Roxanne | Executive Vice President |
Feb 13 '24 |
Sale |
186.86 |
2,848 |
532,177 |
17,569 |
Lagano Roxanne | Executive Vice President |
Feb 12 '24 |
Sale |
197.74 |
363 |
71,780 |
20,417 |
Lagano Roxanne | Executive Vice President |
Jan 18 '24 |
Sale |
191.43 |
923 |
176,690 |
17,569 |
Lagano Roxanne | Executive Vice President |
Dec 18 '23 |
Sale |
198.14 |
923 |
182,883 |
18,492 |
Zoetis Inc Stock (ZTS) Latest News
Jack Daniels Parent Company, EA, Cognizant Among 6 Stocks That Shine When Nvidia Slips: Analysis
Benzinga
Suddenly, There's An Alternative - The Important Case For Wide Moat Dividend Stocks
Seeking Alpha
Zoetis (ZTS) Stock Moves -0.14%: What You Should Know
Zacks Investment Research
Company News for Apr 15, 2024
Zacks Investment Research
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
How's AT&T Handling Things?
The Motley Fool
About Zoetis Inc
Zoetis Inc. discovers, develops, manufactures, and markets veterinary vaccines and medicines in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides medicated feed additives that offer medicines to livestock; and other pharmaceutical products, which comprise allergy and dermatology, pain and sedation, antiemetic, reproductive, and oncology products. In addition, the company offers other product categories, including nutritionals and agribusiness services, as well as products and services in complementary areas, such as biodevices, diagnostics, and genetics. It markets its products to veterinarians, livestock producers, and people who raise and care for farm and companion animals through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Cap:
|
Volume (24h):